BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2467163)

  • 1. Purification of two high molecular weight toxins of Clostridium difficile which are antigenically related.
    von Eichel-Streiber C; Harperath U; Bosse D; Hadding U
    Microb Pathog; 1987 May; 2(5):307-18. PubMed ID: 2467163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A non-haemagglutinating form of Clostridium difficile toxin A.
    Kamiya S; Borriello SP
    J Med Microbiol; 1992 Mar; 36(3):190-7. PubMed ID: 1548692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification and characterization of toxins A and B of Clostridium difficile.
    Sullivan NM; Pellett S; Wilkins TD
    Infect Immun; 1982 Mar; 35(3):1032-40. PubMed ID: 7068210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification and characterisation of Clostridium difficile toxin A by bovine thyroglobulin affinity chromatography and dissociation in denaturing conditions with or without reduction.
    Kamiya S; Reed PJ; Borriello SP
    J Med Microbiol; 1989 Sep; 30(1):69-77. PubMed ID: 2778794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification and characterisation of intracellular toxin A of Clostridium difficile.
    Meng XQ; Kamiya S; Yamakawa K; Ogura H; Nakamura S
    J Med Microbiol; 1993 Jan; 38(1):69-73. PubMed ID: 8418298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunochemical and structural similarities in toxin A and toxin B of Clostridium difficile shown by binding to monoclonal antibodies.
    Rothman SW; Gentry MK; Brown JE; Foret DA; Stone MJ; Strickler MP
    Toxicon; 1988; 26(6):583-97. PubMed ID: 2459808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification and some properties of cytotoxin produced by Clostridium difficile.
    Katoh T; Honda T; Miwatani T
    Microbiol Immunol; 1988; 32(6):551-64. PubMed ID: 3173147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification and characterization of the lethal toxin (alpha-toxin) of Clostridium septicum.
    Ballard J; Bryant A; Stevens D; Tweten RK
    Infect Immun; 1992 Mar; 60(3):784-90. PubMed ID: 1541552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical characterization and biologic actions of two toxins (D-1 and D-2) from Clostridium difficile.
    Banno Y; Kobayashi T; Kono H; Watanabe K; Ueno K; Nozawa Y
    Rev Infect Dis; 1984; 6 Suppl 1():S11-20. PubMed ID: 6426016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification and characterisation of two forms of toxin B produced by Clostridium difficile.
    Torres JF; Lönnroth I
    FEBS Lett; 1988 Jun; 233(2):417-20. PubMed ID: 3133248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification and characterization of Clostridium sordellii hemorrhagic toxin and cross-reactivity with Clostridium difficile toxin A (enterotoxin).
    Martinez RD; Wilkins TD
    Infect Immun; 1988 May; 56(5):1215-21. PubMed ID: 3128481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simplified purification method for Clostridium difficile toxin A.
    Fu SW; Xue J; Zhang YL; Zhou DY
    World J Gastroenterol; 2004 Sep; 10(18):2756-8. PubMed ID: 15309736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Preparation and characterization of monoclonal antibody against Clostridium difficile toxin A].
    Fu SW; Zhou DY; Lai ZS; Xue J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 May; 20(3):376-8. PubMed ID: 15193243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of six murine monoclonal antibodies specific for toxin B of Clostridium difficile.
    Coughlin RT; Annunziato M; Roberson J; Marciani DJ
    Hybridoma; 1994 Apr; 13(2):147-52. PubMed ID: 8050780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile.
    Lyerly DM; Barroso LA; Wilkins TD; Depitre C; Corthier G
    Infect Immun; 1992 Nov; 60(11):4633-9. PubMed ID: 1398977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and preliminary application of monoclonal antibodies to the receptor binding region of Clostridium difficile toxin B.
    Chen W; Liu WE; Li YM; Luo S; Zhong YM
    Mol Med Rep; 2015 Nov; 12(5):7712-20. PubMed ID: 26459027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification and characterization of alpha-toxin of Clostridium oedematiens type A.
    Izumi N; Kondo H; Ohishi I; Sakaguchi G
    Jpn J Med Sci Biol; 1983 Jun; 36(3):135-46. PubMed ID: 6632349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification and characterization of toxin B from Clostridium difficile.
    Meador J; Tweten RK
    Infect Immun; 1988 Jul; 56(7):1708-14. PubMed ID: 3384474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production, purification and characterization of Clostridium difficile toxic proteins different from toxin A and from toxin B.
    Torres JF; Lönnroth I
    Biochim Biophys Acta; 1989 Oct; 998(2):151-7. PubMed ID: 2506935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification and properties of Clostridium difficile cytotoxin B.
    Pothoulakis C; Barone LM; Ely R; Faris B; Clark ME; Franzblau C; LaMont JT
    J Biol Chem; 1986 Jan; 261(3):1316-21. PubMed ID: 3944088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.